FluGen, startup developing universal flu vaccine, raises $5.5M
FluGen, an early-stage company, located at URP, developing vaccine candidates designed to protect against multiple types of influenza, has raised $5.5 million in debt financing....
FluGen, an early-stage company, located at URP, developing vaccine candidates designed to protect against multiple types of influenza, has raised $5.5 million in debt financing....
Invenra, a Madison startup involved in the race to find drugs that will beat cancer, says it is teaming with Merck, one of the world’s leading pharmaceutical companies....
Cellular Dynamics International, the stem cell company founded by UW-Madison stem cell pioneer James Thomson, is backing off on moving its headquarters to Verona and will stay in Madison, at least for now, as it prepares to push forward with its first potential stem cell-based...
Exact Sciences said a major study on its second product in the pipeline — a test for lung cancer — will likely begin in early 2018....
B. Lynn Allen-Hoffman and Stratatech are full of big ideas at University Research Park....
Invenra today announced a collaboration with Merck, known as MSD outside the United States and Canada, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck. ...
In Madison, Wisconsin the tech job market grew 5% in 2013-2014 and a whopping 30% in 2015-2016, making it the market with the most momentum....
A regenerative medicine treatment for skin burns developed by Stratatech could make it to the market more quickly following a regulatory decision announced Tuesday....
Varigen Biosciences, based at URP, received the Qualified New Business Venture certification, which allows investors in qualified startup and early-stage companies to receive a 25 percent state tax credit on the amount they invest in the business....
Stratatech, a University of Wisconsin–Madison spinoff, located at URP, that makes an innovative material designed to speed healing of serious burns has begun a large clinical trial for the “regenerative skin tissue” it has been developing since 2000....